LEIGH SCHMIDT: Open Payments
NPI 1083248579 · ROLLING HILLS ESTATES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,265 in 53 payments from 16 companies in 2025. Trend: 2023 $2,204 · 2024 $4,710 · 2025 $7,265
Consulting: $4,600Food & beverage: $1,453Travel & lodging: $1,193Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $6,180 |
| GENZYME CORPORATION | 9 | $378 |
| Organon LLC | 2 | $172 |
| PFIZER INC. | 5 | $107 |
| ALK-Abello, Inc | 1 | $55 |
| Novo Nordisk Inc | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Sage Therapeutics, LLC | 2 | $46 |
| ABBVIE INC. | 2 | $44 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $39 |
Products named: DUPIXENT, VTAMA, Rhapsido, PREVNAR 20, NUCALA, ZURZUVAE, RINVOQ, NEFFY.
Industry payments across CA — which companies pay providers there.
